Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Share-based Compensation: 2022-2023

Historic Share-based Compensation for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $804,000.

  • Lexeo Therapeutics' Share-based Compensation rose 54.32% to $804,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $12.5 million for FY2024, which is 309.92% up from last year.
  • As of Q4 2023, Lexeo Therapeutics' Share-based Compensation stood at $804,000, which was down 8.01% from $874,000 recorded in Q3 2023.
  • Over the past 5 years, Lexeo Therapeutics' Share-based Compensation peaked at $969,000 during Q2 2023, and registered a low of $397,000 during Q1 2023.
  • Moreover, its 2-year median value for Share-based Compensation was $662,500 (2022), whereas its average is $666,000.
  • Data for Lexeo Therapeutics' Share-based Compensation shows a peak YoY surged of 102.78% (in 2023) over the last 5 years.
  • Over the past 2 years, Lexeo Therapeutics' Share-based Compensation (Quarterly) stood at $521,000 in 2022, then spiked by 54.32% to $804,000 in 2023.
  • Its Share-based Compensation was $804,000 in Q4 2023, compared to $874,000 in Q3 2023 and $969,000 in Q2 2023.